Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Seifert

Showing results (71-80 of 240) with videos related to

Pageof 24
Sort By:
The Journal of Antimicrobial Chemotherapy|February 2, 2012
In vitro activity of the siderophore monosulfactam BAL30072 against meropenem-non-susceptible Acinetobacter baumanniiPaul G Higgins, Danuta Stefanik, Malcolm G P Page, et al.
The Journal of Antimicrobial Chemotherapy|January 17, 2009
Nosocomial spread of OXA-23 and OXA-58 beta-lactamase-producing Acinetobacter baumannii in a Bulgarian hospitalTemenuga Stoeva, Paul G Higgins, Encho Savov, et al.
Antibiotics (Basel, Switzerland)|July 29, 2023
In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant <i>Acinetobacter baumannii</i> IsolatesHarald Seifert, Carina Müller, Danuta Stefanik, et al.
GMS Infectious Diseases|January 24, 2019
Temporal trends of the in vitro activity of tigecycline and comparator antibiotics against clinical aerobic bacterial isolates collected in Germany, 2006-2014: results of the Tigecycline Evaluation and Surveillance Trial (TEST)Michael Kresken, Barbara Körber-Irrgang, Christian Petrik, et al.
The Journal of Antimicrobial Chemotherapy|June 10, 2020
In vitro activity of sulbactam/durlobactam against global isolates of carbapenem-resistant Acinetobacter baumanniiHarald Seifert, Carina Müller, Danuta Stefanik, et al.
International Journal of Antimicrobial Agents|January 11, 2012
Comparative Activity of Carbapenem Testing (COMPACT) study in GermanyGiuseppe Valenza, Harald Seifert, Sabine Decker-Burgard, et al.
Open Forum Infectious Diseases|May 22, 2019
Effect of Clinically Uninfected Orthopedic Implants and Pacemakers/AICDs in Low-Risk <i>Staphylococcus aureus</i> Bloodstream Infection on Crude Mortality Rate: A Post Hoc Analysis of a Large Cohort StudyAchim J Kaasch, Winfried V Kern, Insa Joost, et al.
Journal of Clinical Microbiology|January 9, 2003
Bloodstream infection in neutropenic cancer patients related to short-term nontunnelled catheters determined by quantitative blood cultures, differential time to positivity, and molecular epidemiological typing with pulsed-field gel electrophoresisHarald Seifert, Oliver Cornely, Kerstin Seggewiss, et al.
Journal of Medical Microbiology|September 10, 2011
Interlaboratory reproducibility of DiversiLab rep-PCR typing and clustering of Acinetobacter baumannii isolatesPaul G Higgins, Andrea M Hujer, Kristine M Hujer, et al.
Journal of Clinical Microbiology|February 5, 2002
Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groupsNicholas M Anstey, Bart J Currie, Marilyn Hassell, et al.
Pageof 24

Showing results (71-80 of 240) with videos related to

Sort By:
Pageof 24
The Journal of Antimicrobial Chemotherapy|February 2, 2012
In vitro activity of the siderophore monosulfactam BAL30072 against meropenem-non-susceptible Acinetobacter baumanniiPaul G Higgins, Danuta Stefanik, Malcolm G P Page, et al.
The Journal of Antimicrobial Chemotherapy|January 17, 2009
Nosocomial spread of OXA-23 and OXA-58 beta-lactamase-producing Acinetobacter baumannii in a Bulgarian hospitalTemenuga Stoeva, Paul G Higgins, Encho Savov, et al.
Antibiotics (Basel, Switzerland)|July 29, 2023
In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant <i>Acinetobacter baumannii</i> IsolatesHarald Seifert, Carina Müller, Danuta Stefanik, et al.
GMS Infectious Diseases|January 24, 2019
Temporal trends of the in vitro activity of tigecycline and comparator antibiotics against clinical aerobic bacterial isolates collected in Germany, 2006-2014: results of the Tigecycline Evaluation and Surveillance Trial (TEST)Michael Kresken, Barbara Körber-Irrgang, Christian Petrik, et al.
The Journal of Antimicrobial Chemotherapy|June 10, 2020
In vitro activity of sulbactam/durlobactam against global isolates of carbapenem-resistant Acinetobacter baumanniiHarald Seifert, Carina Müller, Danuta Stefanik, et al.
International Journal of Antimicrobial Agents|January 11, 2012
Comparative Activity of Carbapenem Testing (COMPACT) study in GermanyGiuseppe Valenza, Harald Seifert, Sabine Decker-Burgard, et al.
Open Forum Infectious Diseases|May 22, 2019
Effect of Clinically Uninfected Orthopedic Implants and Pacemakers/AICDs in Low-Risk <i>Staphylococcus aureus</i> Bloodstream Infection on Crude Mortality Rate: A Post Hoc Analysis of a Large Cohort StudyAchim J Kaasch, Winfried V Kern, Insa Joost, et al.
Journal of Clinical Microbiology|January 9, 2003
Bloodstream infection in neutropenic cancer patients related to short-term nontunnelled catheters determined by quantitative blood cultures, differential time to positivity, and molecular epidemiological typing with pulsed-field gel electrophoresisHarald Seifert, Oliver Cornely, Kerstin Seggewiss, et al.
Journal of Medical Microbiology|September 10, 2011
Interlaboratory reproducibility of DiversiLab rep-PCR typing and clustering of Acinetobacter baumannii isolatesPaul G Higgins, Andrea M Hujer, Kristine M Hujer, et al.
Journal of Clinical Microbiology|February 5, 2002
Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groupsNicholas M Anstey, Bart J Currie, Marilyn Hassell, et al.
Pageof 24